Orca Bio

Interested in learning more about Orca Bio’s investigational high-precision cell therapies? We partnered with The EBMT on a video that highlights the significant unmet need that exists for patients with #bloodcancer today, Orca Bio’s unique approach, and the potential for our investigational products to change the treatment paradigm. You can check out the video here: https://bit.ly/3Jku5GE #EBMT24 #bloodcancer #AML #oncology #leukemia

Last week we were honored to have Robyn, Orca-T recipient and clinical trial participant, share her inspirational patient journey with our team. This month marks five years since Robyn received Orca-T, our investigational T-cell immunotherapy. In those five years, Robyn has had the opportunity to celebrate birthdays, holidays and important milestones with her family and friends, cancer-free. It’s stories like Robyn’s that reinforce the importance of what we are trying to accomplish at Orca Bio, and why we all come to work each day. #patientsfirst #bloodcancer #oncology #leukemia #celltherapy

The Leukemia & Lymphoma Society recently asked how survivors of #bloodcancer would sum up their experience in just six words – and the responses are both inspiring and empowering. At Orca Bio, we are on a mission to ensure there are more survivors from blood cancers like #AML, #MDS and #ALL. To learn more: https://bit.ly/3W04Xe5

Team Orca Bio wishes you a safe and happy Independence Day!

#ICYMI, Dr. Rawan Faramand of Moffit Cancer Center presented encouraging clinical data on our lead investigational T-cell immunotherapy, Orca-T, at #ASCO24. Speaking to CGTLive, Dr. Faramand described Orca-T’s potential to transform care for patients with acute myeloid leukemia, or #AML. Check out the video interview: https://bit.ly/3REh6UM #bloodcancer #AML #oncology #leukemia #celltherapy

Meet Adams Hendrickson, Associate Director of Finance and Operations on #TeamOrcaBio and this month’s #employeespotlight. Adams oversees the financial planning & analysis, contracting and procurement functions at Orca Bio. Adams is a California native and has spent his career working in the pharmaceutical industry at companies such as BioMarin, Medivation and Astex Pharmaceuticals. Prior to joining Orca Bio, Adams earned an MBA from the Haas School of Business at the University of California, Berkeley. Learn more about our exceptional team: https://bit.ly/3Rfnx0e

Today, we commemorate #Juneteenth, the United States’ second independence day. At Orca Bio we reflect on and celebrate this monumental day and significant milestone in the fight for freedom. Join us in learning more: https://s.si.edu/4aHg7K0

Join us in welcoming Katie Chaddock to the Orca Bio team as Site Head, Commercial Manufacturing. Katie brings over 25 years of experience manufacturing and supplying high quality pharmaceutical products to patients in need, most recently as Johnson & Johnson’s Head of Competitiveness, Autologous Therapies. Katie’s work has spanned many areas including generic medications, rare disease therapies and a pandemic fighting Covid vaccine. We’re thrilled to have you, Katie! #TeamOrcaBio #celltherapy #oncology

Join us in celebrating #PrideMonth! We proudly support the LGBTQ+ community and are committed to supporting an inclusive and equitable environment. Here at Orca Bio, fostering a sense of belonging on our team enhances each and every individual’s experience as we work toward our mission to change the lives of patients through novel cell therapies.

We’re pleased to announce the completion of enrollment in Precision-T, the pivotal Phase 3 study of our lead investigational allogeneic T-cell immunotherapy, Orca-T. To learn more: https://bit.ly/3X7Og2E #bloodcancer #AML #oncology #leukemia #celltherapy